Orient Pharma Co., Ltd. (TPEX: 4166)
Health Care · Pharmaceuticals · TW
NT$24.20
-0.82% today · -4.0% 1Y
Orient Pharma Co., Ltd. (TPEX: 4166) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $183.94M and employs 173 people.
Over the last twelve months the share price has lost 4.0%, trading between 22.40 and 29.60.
Tweenvest scores Orient Pharma Co., Ltd. across four factors: quality 73/100, value 48/100, growth 89/100. Its strongest factor is growth.
4166 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $183.94M
- Revenue (TTM)
- $47.66M
- P/E
- 24.73
- EPS
- 0.98
- Dividend yield
- —
- Beta (5Y)
- 0.04
- 52-week high
- NT$29.60
- 52-week low
- NT$22.40
- Avg volume (3M)
- —
- Shares outstanding
- 243.03M
- Employees
- 173
- Next earnings
- —
About Orient Pharma Co., Ltd.
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
- ISIN
- TW0004166004
- Founded
- 2008
- Listed since
- Jun 20, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Yoda Pharmaceuticals Inc.TPEX: 7829 | $185.57M | NT$59.70 | +1.02% |
| Dawnrays Pharmaceutical (Holdings) LimitedSEHK: 2348 | $184.28M | HK$0.96 | -0.52% |
| Formosa Laboratories, Inc.TWSE: 4746 | $184.10M | NT$48.95 | +1.77% |
| Alar Pharmaceuticals Inc.TPEX: 6785 | $184.05M | NT$88.10 | -6.97% |
| Samjin Pharmaceuticals Co., Ltd.KOSE: A005500 | $183.27M | ₩20,100.00 | +5.35% |
| Fidson Healthcare PlcNGSE: FIDSON | $180.69M | ₦83.00 | +1.22% |
| Oramed Pharmaceuticals Inc.NasdaqCM: ORMP | $180.12M | $4.33 | -3.56% |
| Journey Medical CorporationNasdaqCM: DERM | $178.10M | $6.31 | -4.54% |
Figures last refreshed Oct 11, 2026.